Justin Fairchild
Corporate Officer/Principal chez PORTAGE BIOTECH INC.
Profil
Justin Fairchild is currently working as Vice President-Development at Portage Biotech, Inc. and Vice President-Clinical Development at The Parker Institute For Cancer Immunotherapy.
He completed his undergraduate degree from Colgate University and his graduate degree from Johns Hopkins Bloomberg School of Public Health.
Postes actifs de Justin Fairchild
| Sociétés | Poste | Début |
|---|---|---|
| PORTAGE BIOTECH INC. | Corporate Officer/Principal | 18/08/2022 |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Directeur Technique/Scientifique/R&D | - |
Formation de Justin Fairchild
| Johns Hopkins Bloomberg School of Public Health | Graduate Degree |
| Colgate University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PORTAGE BIOTECH INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |
